Study Details
A study to evaluate the efficacy and safety in kidney transplant recipients when changed from cyclosporine to tacrolimus prolonged-release capsule or tacrolimus capsule
Clinicaltrials.gov ID
Astellas Study ID
ACNKTxCon
EudraCT ID
N/A
Condition
Kidney Transplants
Phase
Phase 4
Age
18 years - 65 years
Sex
Female & Male
Product
N/A
Type
Interventional
Trial Dates
Jul 2013 - Mar 2015
Masking
None (Open Label)
Enrollment number
17
A randomized, open-label, multi-center clinical trial to compare efficacy and safety of cyclosporine-based and switching cyclosporine to tacrolimus of two forms-based immunosuppressive therapy in renal transplant (KTx) recipients
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A study to evaluate the efficacy and safety in kidney transplant recipients when changed from cyclosporine to tacrolimus prolonged-release capsule or tacrolimus capsule? Contact us by filling our your information to the right and we’ll respond to you.